The present invention relates to a protein comprising SEQ ID NO:1 (mature form of SLURP-1) and to a composition comprising the same for use in the treatment of an ocular disease, in particular in inducing or accelerating cicatrisation, in reducing inflammation, and/or in preventing infection in the eye of a subject.